BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17090319)

  • 1. Defining the gene expression signature of rhabdomyosarcoma by meta-analysis.
    Romualdi C; De Pittà C; Tombolan L; Bortoluzzi S; Sartori F; Rosolen A; Lanfranchi G
    BMC Genomics; 2006 Nov; 7():287. PubMed ID: 17090319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel genes expressed during rhabdomyosarcoma differentiation using cDNA microarrays.
    Carey KA; Segal D; Klein R; Sanigorski A; Walder K; Collier GR; Cameron-Smith D
    Pathol Int; 2006 May; 56(5):246-55. PubMed ID: 16669873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative splicing of MEF2C pre-mRNA controls its activity in normal myogenesis and promotes tumorigenicity in rhabdomyosarcoma cells.
    Zhang M; Zhu B; Davie J
    J Biol Chem; 2015 Jan; 290(1):310-24. PubMed ID: 25404735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Full transcriptome analysis of rhabdomyosarcoma, normal, and fetal skeletal muscle: statistical comparison of multiple SAGE libraries.
    Schaaf GJ; Ruijter JM; van Ruissen F; Zwijnenburg DA; Waaijer R; Valentijn LJ; Benit-Deekman J; van Kampen AH; Baas F; Kool M
    FASEB J; 2005 Mar; 19(3):404-6. PubMed ID: 15629888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fragile histidine triad expression in rhabdomyosarcoma].
    Wang SL; Yang GH; Bu H; Guo LX; Zhou Q; Zhang HY; Ye L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):176-8. PubMed ID: 15071908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.
    Cessna MH; Zhou H; Perkins SL; Tripp SR; Layfield L; Daines C; Coffin CM
    Am J Surg Pathol; 2001 Sep; 25(9):1150-7. PubMed ID: 11688574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Proprotein Convertase Furin Contributes to Rhabdomyosarcoma Malignancy by Promoting Vascularization, Migration and Invasion.
    Jaaks P; D'Alessandro V; Grob N; Büel S; Hajdin K; Schäfer BW; Bernasconi M
    PLoS One; 2016; 11(8):e0161396. PubMed ID: 27548722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-203, a tumor suppressor frequently down-regulated by promoter hypermethylation in rhabdomyosarcoma.
    Diao Y; Guo X; Jiang L; Wang G; Zhang C; Wan J; Jin Y; Wu Z
    J Biol Chem; 2014 Jan; 289(1):529-39. PubMed ID: 24247238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of insulin-like growth factor pathway proteins in rhabdomyosarcoma: IGF-2 expression is associated with translocation-negative tumors.
    Makawita S; Ho M; Durbin AD; Thorner PS; Malkin D; Somers GR
    Pediatr Dev Pathol; 2009; 12(2):127-35. PubMed ID: 18788888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members.
    Megiorni F; Cialfi S; McDowell HP; Felsani A; Camero S; Guffanti A; Pizer B; Clerico A; De Grazia A; Pizzuti A; Moles A; Dominici C
    BMC Cancer; 2014 Nov; 14():880. PubMed ID: 25427715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development.
    Missiaglia E; Selfe J; Hamdi M; Williamson D; Schaaf G; Fang C; Koster J; Summersgill B; Messahel B; Versteeg R; Pritchard-Jones K; Kool M; Shipley J
    Genes Chromosomes Cancer; 2009 Jun; 48(6):455-67. PubMed ID: 19235922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global DNA methylation profiling uncovers distinct methylation patterns of protocadherin alpha4 in metastatic and non-metastatic rhabdomyosarcoma.
    Tombolan L; Poli E; Martini P; Zin A; Millino C; Pacchioni B; Celegato B; Bisogno G; Romualdi C; Rosolen A; Lanfranchi G
    BMC Cancer; 2016 Nov; 16(1):886. PubMed ID: 27842508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma.
    Coda DM; Lingua MF; Morena D; Foglizzo V; Bersani F; Ala U; Ponzetto C; Taulli R
    Cell Cycle; 2015; 14(9):1389-402. PubMed ID: 25644430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA dysregulation in rhabdomyosarcoma: a new player enters the game.
    Li Z; Yu X; Shen J; Liu Y; Chan MT; Wu WK
    Cell Prolif; 2015 Oct; 48(5):511-6. PubMed ID: 26202219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDK1 and CCNB1 as potential diagnostic markers of rhabdomyosarcoma: validation following bioinformatics analysis.
    Li Q; Zhang L; Jiang J; Zhang Y; Wang X; Zhang Q; Wang Y; Liu C; Li F
    BMC Med Genomics; 2019 Dec; 12(1):198. PubMed ID: 31870357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis of a muscle ankyrin-repeat protein, Arpp, in paraffin-embedded tumors: evaluation of Arpp as a tumor marker for rhabdomyosarcoma.
    Ishiguro N; Motoi T; Osaki M; Araki N; Minamizaki T; Moriyama M; Ito H; Yoshida H
    Hum Pathol; 2005 Jun; 36(6):620-5. PubMed ID: 16021567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling the molecular difference between Patched- and p53-dependent rhabdomyosarcoma.
    Kappler R; Bauer R; Calzada-Wack J; Rosemann M; Hemmerlein B; Hahn H
    Oncogene; 2004 Nov; 23(54):8785-95. PubMed ID: 15480423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAX7 is a required target for microRNA-206-induced differentiation of fusion-negative rhabdomyosarcoma.
    Hanna JA; Garcia MR; Go JC; Finkelstein D; Kodali K; Pagala V; Wang X; Peng J; Hatley ME
    Cell Death Dis; 2016 Jun; 7(6):e2256. PubMed ID: 27277678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LEF1 reduces tumor progression and induces myodifferentiation in a subset of rhabdomyosarcoma.
    Dräger J; Simon-Keller K; Pukrop T; Klemm F; Wilting J; Sticht C; Dittmann K; Schulz M; Leuschner I; Marx A; Hahn H
    Oncotarget; 2017 Jan; 8(2):3259-3273. PubMed ID: 27965462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of pannexin 1-regulated genes, interactome, and pathways in rhabdomyosarcoma and its tumor inhibitory interaction with AHNAK.
    Xiang X; Langlois S; St-Pierre ME; Blinder A; Charron P; Graber TE; Fowler SL; Baird SD; Bennett SAL; Alain T; Cowan KN
    Oncogene; 2021 Mar; 40(10):1868-1883. PubMed ID: 33564071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.